ArticleJournal of thoracic disease2022

Pirfenidone inhibits cell fibrosis in connective tissue disease-associated interstitial lung disease by targeting the TNF-α/STAT3/KL6 pathway.

Yanhua Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.